BioSpace News Archive

Policy

Seattle Cancer Care Alliance One of Only 51 Centers Certified for CAR-T Therapy

Because of the potential for significant side effects of CAR-T therapies, the FDA requires Risk Evaluation and Mitigation Strategies (REMS) programs. The Bezos Family Immunotherapy Clinic at the Seattle Cancer Care Alliance is one of those approved sites.

July 8, 2018
·
4 min read
·
Mark Terry
Business

Movers and Shakers in the Biopharma Industry for July 9

It was a slow week as far as changes were made at the executive level in the biopharma industry. Still, three companies made key appointments that will potentially spur strategic growth for stakeholders.

July 8, 2018
·
2 min read
·
Alex Keown
Business

MVPvets Partners with Veterati to Match Veterans with Professional Mentors

MVPvets announced a new partnership with Veterati to connect U.S. military veterans with a network of hundreds of mentors through an online mentoring platform.

July 8, 2018
·
2 min read
Business

Polaris Announces Drs. James Allison and Padmanee Sharma Joining its Scientific Advisory Board

Polaris Pharmaceuticals, Inc. announced that James Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D. have joined its Scientific Advisory Board.

July 8, 2018
·
3 min read
Drug Development

PBT434 Data to be Presented at the International Congress of Parkinson’s Disease and Movement Disorders

Prana’s PBT434 prevents neuronal loss in a new model of neurodegeneration

July 8, 2018
·
2 min read
Job Trends

Paragon 28® announces launch of non-sterile instrumentation to aid surgeons in collection of autogenous bone - Bone Graft Harvesting System

Paragon 28 has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefitting both the surgeon and patient.

July 8, 2018
·
2 min read
Deals

CORRECTING and REPLACING Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.

$133 Million Deal Adds European Early Development Center of Excellence to Global Network CORRECTION...by Catalent, Inc.

July 8, 2018
·
10 min read
Business

Benitec Announces Global Licensing Agreement for BB-301 for Treatment of Oculopharyngeal Muscular Dystrophy and Broad Platform Collaboration with Axovant

Benitec Biopharma Limited announced that it has licensed to Axovant Sciences (“Axovant”) the exclusive global rights for BB-301

July 8, 2018
·
7 min read